SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-024223
Filing Date
2021-05-03
Accepted
2021-05-03 16:01:57
Documents
2
Period of Report
2021-04-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1612
2 POWER OF ATTORNEY ea139992ex24-3gemayel_gemini.htm EX-24 6740
  Complete submission text file 0001213900-21-024223.txt   9759
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address
GEMAYEL GEORGES (Reporting) CIK: 0001256088 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39438 | Film No.: 21883454

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Issuer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences